Specialty Pharmacy Eases Financial Burden Tops SPT Week in Review

Top news of the week from Specialty Pharmacy Times

5. ZAP Gene is Crucial First Step in Cells Identifying HIV

A study sought to determine how HIV avoids the antiviral protein, zinc-finger antiviral protein. Read more.

4. Chemotherapy-Free Treatment Combo Achieves High Rates of MRD Negativity in CLL

A prospective analysis of the CLL14 trial showed that fixed-duration treatment of venetoclax plus obinutuzumab achieved high rates of undetectable minimal residual disease. Read more.

3. Gabapentinoids Prescriptions Grew Twofold in 10 Years

A study found that the total prescriptions for gabapentinoid medications grew from 1.2 million to 3.5 million between 2005-2015. Read more.

2. Mosunetuzumab Induces Complete Remissions in NHL After CAR T-Cell Therapy Relapse

A novel, off-the-shelf bispecific antibody could serve as a new treatment option for patients with non-Hodgkin lymphoma who don’t respond to CAR T-cell therapy. Read more.

1. Specialty Pharmacy Eases Financial Burden for Patients on Oral Therapies for Hematologic Malignancies

Patients receiving novel oral therapeutics often have a high dependence on financial assistance; specialty pharmacies may help facilitate access to these therapies. Read more.